CARILLON TOWER ADVISERS, INC. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 137 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$20,095,442,000
+100593.7%
3,948,0240.0%0.13%
-3.6%
Q3 2019$19,957,000
-18.1%
3,948,0240.0%0.14%
-16.8%
Q2 2019$24,359,000
+33.0%
3,948,0240.0%0.17%
+28.5%
Q1 2019$18,318,000
+10.5%
3,948,0240.0%0.13%
-7.1%
Q4 2018$16,582,000
-33.0%
3,948,0240.0%0.14%
-20.9%
Q3 2018$24,745,000
-22.0%
3,948,0240.0%0.18%
-29.2%
Q2 2018$31,742,000
+13.1%
3,948,0240.0%0.25%
+14.7%
Q1 2018$28,070,000
+28.8%
3,948,024
+7.8%
0.22%
-6.0%
Q4 2017$21,790,0003,662,1180.23%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,583,925$8,007,0001.48%
Phocas Financial Corp. 1,022,708$5,169,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,776,490$8,980,0000.32%
FARALLON CAPITAL MANAGEMENT LLC 7,350,000$37,154,0000.28%
NEXPOINT ASSET MANAGEMENT, L.P. 716,880$3,624,0000.23%
J. Goldman & Co LP 499,698$2,526,0000.19%
PINNACLE ASSOCIATES LTD 1,257,098$6,355,0000.15%
CARILLON TOWER ADVISERS, INC. 3,948,024$19,957,0000.14%
EAGLE ASSET MANAGEMENT INC 4,504,094$22,768,0000.12%
Worth Venture Partners, LLC 32,956$167,0000.10%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders